{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-026319","form_type":"8-K","ticker":"ELAN","cik":"0001739104","company_name":"Elanco Animal Health Inc","filed_at":"2022-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.995910+00:00","generated_at":"2026-06-27T04:56:30.705569+00:00","sec_items":["2.02","5.03","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Elanco FY21 rev $4,765M, adj EPS $1.05; Q4 adj EPS $0.21 (+75%); FY22 adj EPS guidance $1.18-1.24","bullets":["Full year 2021 revenue $4,765M (+46% YoY); reported EPS -$0.97, adjusted EPS $1.05.","Q4 2021 revenue $1,113M (-2% YoY); adjusted EPS $0.21 (+75% YoY).","FY22 guidance: revenue $4,745-$4,800M, adjusted EPS $1.18-$1.24.","Restructuring: ~380 positions cut; synergy target raised to $345M by 2023.","Board eliminated supermajority voting and adopted proxy access for 3%+ shareholders owning ≥3 years."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-026319","json":"https://secwatch.observer/filing/0001104659-22-026319.json","markdown":"https://secwatch.observer/filing/0001104659-22-026319.md","text":"https://secwatch.observer/filing/0001104659-22-026319.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739104/000110465922026319/0001104659-22-026319-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739104/000110465922026319/tm227491d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:56:30.705569+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}